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INTRODUCTION
Thyroid dysfunction is common, particularly in older peo-
ple.
1 Considerable efforts have been made to elucidate associ-
ations of thyroid dysfunction with both somatic and mental 
disorders, but results have been controversial.
2 In the field of ge-
riatric psychiatry, associations with cognitive function and de-
pression have received particular attention. Thyroid stimulating 
hormone (TSH) is a sensitive marker for abnormal thyroid 
function, and therefore most studies have included this assay.
3,4
With respect to cognitive function in older people, some 
studies have found low serum TSH levels to be associated with 
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cognitive impairment or dementia,
5,6 others have found no as-
sociations,
7,8 and others have found high TSH levels to be as-
sociated with worse working memory.
9,10 The Framingham 
Study found that both low and high TSH levels were associat-
ed with an increased risk of incident dementia.
11
Regarding late-life depression, studies have found associa-
tions between high serum TSH levels and depression
12 as well 
as an increased risk of hospitalization with affective disorder.
13 
However, other studies have found no associations between 
thyroid dysfunction and depression.
7,8,14,15
Overall, these research questions remain controversial and 
require further investigation. Using data from a sample of com-
munity dwelling Korean elders, we investigated associations of 
serum TSH levels with cognitive impairment and depression 
after controlling for potential confounders.
METHODS
Study area and population
In collaboration with the 10/66 Dementia in Developing 
Countries Research Program,
16 several consecutive communi-
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ty surveys of psychiatric morbidity in late-life have been carried 
out in Gwangju, South Korea from 2001 to 2006. Similar proto-
cols were administered for the studies, and the study results 
from data obtained in 2001 and 2003 have been published pre-
viously.
17,18 Serum TSH levels were assayed in a further cross-
sectional survey conducted in 2004. A geographic catchment 
area design was used to obtain the sample. This area, Hakwoon, 
is located in the inner, very urbanized compartment of Gwangju 
city. It covers a land area of 11 km
2 and has an estimated pop-
ulation of 14,518 of whom 1,499 (10.4%) were known to be 
aged 65 or over from national registration lists. Potential partic-
ipants for the study were recruited from this latter group.
Interviews and procedures
Before the survey, a letter explaining the study was sent to all 
potential participants. Contact was made by home visits, re-
peated at least two times if no reply was obtained. Single stage 
assessments for interview, measurements and blood sampling 
were carried out by three research nurses who were trained for 
this particular study and supervised by the project psychiatrist 
throughout the survey period. All participants gave informed 
consent, and the study was approved by the Chonnam Nation-
al University Hospital Institutional Review Board.
Serum TSH and classification of thyroid function
Blood samples were collected in a fasting state, carried out in 
the mornings where possible. Serum TSH levels were meas 
ured by using a chemiluminescent immunoassay (Cobas: Roche 
Diagnotics, West Sussex, UK) in the Clinical Laboratory of 
Chonnam National University Hospital. The laboratory refer-
ence range was 0.50-4.50 mIU/L. For the analyses presented 
here, we classified thyroid function according to serum levels 
of TSH: 1) hyperthyroid state (<0.50 mIU/L); 2) euthyroid 
state (0.50-4.50 mIU/L); and 3) hypothyroid state (>4.50 
mIU/L). The euthyroid state was further divided into tertiles 
for additional analysis. Use of levothyroxine was ascertained 
from inventories taken of medication use in survey partici-
pants.
Cognitive impairment
Cognitive function was evaluated using the Community Screen-
ing Interview for Dementia (CSID), which is a 32-item cognitive 
test administered to the participants (20 min) and 26-item infor-
mant interview about the participants daily functioning and gen-
eral health lasting around 15 minutes.
19 Three summary scores can 
be generated from CSID: 1) the cognitive score (COGSCORE), an 
item-weighted total score from the participants cognitive test; 
2) the informant score (RELSCORE), an unweighted total score 
from the informant interview; and 3) the discriminant function 
score (DFSCORE), a weighted score combining COGSCORE 
and RELSCORE. DFSCORE has a validated cutoff, and has 
achieved 87% sensitivity and 83% specificity for a clinical di-
agnosis of DSM-III-R dementia.
19 The CSID was translated into 
Korean (CSID-K), and its reliability and validity in this language 
have been previously evaluated and described.
20 The standard 
cut-off for the DFSCORE was administered to define cognitive 
impairment in the study.
Depression
Depression was assessed using the community version of the 
Geriatric Mental State diagnostic schedule (GMS B3).
21 This is 
a fully structured diagnostic instrument in wide international 
use with an accompanying computerised algorithm. The GMS 
B3 was translated into Korean according to a formal standard-
ization process.
22 Diagnosis of depression in the last month was 
generated using the Automated Geriatric Examination for Com-
puter Assisted Taxonomy (AGECAT) algorithm. Participants rat-
ed as AGECAT 3, 4, and 5 are considered to be likely cases, those 
rated as 1 and 2 are considered to be sub-cases, and those rated as 
0 to have no relevant symptomatology. As in other studies, a ‘stage 
one’ (non-hierarchical) confidence level of 3 or above in the AGE-
CAT algorithm was used in this study to define depression of 
clinical significance.
Other covariates
Demographic data on age, gender, and education were re-
corded. Smoking history was ascertained. Daily physical activ-
ity, taking into account both work and leisure activity, was as-
certained and sedentary lifestyle was defined as a binary variable. 
Resting blood pressure (BP) was taken with an automatic sphyg-
momanometer on the left arm in the sitting position. Self-report-
ed diagnosis of and treatment history for diabetes were record-
ed. Blood assays for total cholesterol and albumin were conducted, 
as these had been found to be potential confounding factors in 
other similar studies.
7,8
Statistical analyses
Statistical analyses were carried out using SPSS 12.0 software. 
Data on demographic and clinical characteristics by the catego-
ries of thyroid function were compared using analysis of vari-
ance or χ2 (Fisher’s exact) tests as appropriate. Unadjusted associ-
ations of serum TSH levels (from lower to higher) with CSID 
caseness and GMS depression were estimated by χ2 tests (linear 
terms). For regression analyses, the middle 2nd tertile of the eu-
thyroid state was treated as reference category. Four adjusted 
models were used for each outcome: model 1 included age, 
gender and education; model 2 included model 1 plus smoking 
and physical activity; model 3 included model 2 plus systolic BP, 
diabetes mellitus, total cholesterol, and albumin; and model 4 in-
cludes model 3 plus levothyroxine treatment and depression.266  Psychiatry Investig 2010;7:264-269
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RESULTS
Recruitment
Of 1,499 inhabitants aged 65 or over identified from regis-
tration lists, 766 (51%) completed the interview with research 
nurses. Of the remainder, contact could not be established with 
447 (30%), 225 (15%) refused to participate by elders or their 
family members, 54 (3%) had no fixed abode, and 7 (1%) had 
died before the visit. No significant differences were observed 
in age (mean ages, 72.6 and 72.9 respectively) and gender ratio 
(60% and 56% female, respectively) between participants and 
non-participants (all p-values >0.1).
Of 766 participants to the interview, 495 (65%) agreed to a 
blood test and comprised the study sample. No significant dif-
ferences were observed between the participants and non-par-
ticipants at this stage in terms of age (mean ages, 72.4 and 72.9 
respectively), gender (61% and 59% female), education (mean 
years, 8.0 and 8.1), CSID caseness (8.7% and 9.6%), and GMS 
depression (15.8% and 15.6%) (all p-values >0.1).
Characteristics of the participants by thyroid function
Thyroid function categories within the sample are described 
in the first through third rows of Table 1. According to the se-
rum TSH levels, 3% of the participants were in a hyperthyroid 
state, 7% were in a hypothyroid state, and 90% were euthyroid. 
The mean (SD) TSH level was 2.1 (1.8) mIU/L. Levothyroxine 
was taken by 36 (7%) participants. Other demographic and 
clinical characteristics are compared by thyroid states in the 
fourth through last rows of Table 1. The proportion of current 
smokers was significantly higher in the hyperthyroid group. 
However, no other differences were found between categories.
Unadjusted associations with cognitive impairment
and depression
Unadjusted associations of thyroid function with cognitive 
impairment and depression are illustrated in Figure 1. The prev-
alence of cognitive impairment was highest in the hyperthyroid 
group, and gradually decreased across euthyroid to hypothyroid 
ranges. However, the prevalence of depression did not marked-
ly change across the range of thyroid function.
Adjusted associations with cognitive 
impairment and depression
Regression analyses for cognitive impairment as an outcome 
are summarised in Table 2. Compared to the reference catego-
ry (2nd tertile of euthyroid state), cognitive impairment was 
significantly raised in the hyperthyroid group, but did not sig-
nificantly differ across other categories, although odds ratios 
remained in the directions originally observed and strengths 
of association were increased in the adjusted models. In a fur-
ther regression analysis on entering the thyroid function cate-
gories as an ordinal variable on one degree of freedom, the 
odds ratio (95% confidence interval) for cognitive impairment 
was 1.61 (1.12-2.30) per group increment in the full adjusted 
model. No significant associations were found in regression 
analyses between thyroid function categories and depression 
(data not shown).
DISCUSSION
In a community dwelling Korean elderly population, we 
found a significant association between lower serum TSH lev-
els (<0.5 mIU/L) indicative of hyperthyroidism and cognitive 
Table 1. Characteristics of the participants by thyroid status
Total 
participants
Hyperthyroid 
state
Euthyroid state Hypothyroid 
state
p-value*
Tertile 1 Tertile 2 Tertile 3
Participants, N (%) 0 495 (100) 00 14 (3) 0 147 (30) 0 149 (30) 0 148 (30) 00 37 (7)
TSH level, mIU/L range 0.02-17.21 0.02-0.49 0.50-1.28 1.29-1.96 1.97-4.50 4.51-17.21
Levothyroxine treatment, N (%) 00 36 (7) 000 1 (7) 000 9 (6) 00 12 (8) 00 11 (7) 000 3 (8) 0.655
Age, mean (SD) years 072.4 (5.6) 073.8 (5.4) 072.1 (5.6) 072.6 (5.9) 072.2 (5.4) 073.2 (5.8) 0.633
Gender, N (%) female 0 301 (61) 000 7 (50) 00 88 (60) 00 89 (60) 00 89 (60) 00 28 (76) 0.185
Education, mean (SD) years 008.0 (5.6) 008.0 (6.9) 008.4 (5.7) 007.7 (5.5) 008.1 (5.8) 007.0 (5.1) 0.623
Current smoker, N (%) 0 145 (29) 000 8 (57) 00 45 (31) 00 49 (33) 00 39 (26) 000 4 (11) 0.006
Physical inactivity, N (%) 0 153 (31) 000 4 (29) 00 42 (29) 00 48 (32) 00 45 (30) 00 14 (38) 0.410
Systolic BP, mean (SD) mmHg 138.2 (20.4) 142.6 (19.3) 135.3 (18.6) 141.3 (21.7) 138.0 (19.9) 136.2 (23.1) 0.121
Diastolic BP, mean (SD) mmHg 080.6 (11.6) 082.4 (8.7) 079.5 (11.5) 081.1 (12.1) 081.1 (11.2) 079.8 (12.8) 0.663
Diabetes mellitus, N (%) 00 84 (17) 000 4 (29) 00 18 (12) 00 26 (17) 00 31 (21) 000 5 (14) 0.401
Total cholesterol, mean (SD) mg/dL 178.8 (36.4) 178.7 (35.3) 180.7 (37.2) 177.1 (36.5) 176.3 (33.8) 187.6 (43.2) 0.465
Albumin, mean (SD) mg/dL 004.3 (0.4) 004.3 (0.3) 004.2 (0.4) 004.3 (0.4) 004.3 (0.4) 004.4 (0.3) 0.715
*analysis of variance or χ2 (Fisher’s exact) tests as appropriate. TSH: thyroid stimulating hormone, BP: blood pressureJM Kim et al. 
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impairment, while no associations were found between TSH 
levels and depression.
Serum TSH assay is very responsive to minute changes in 
circulating thyroid hormone levels and so it is a sensitive and 
specific test.
4 In the present study, a hyperthyroid state was 
present in 3% and hypothyroid state in 7% of the participants. 
These were similar to other previous studies with older com-
munity samples, where the below normal (hyperthyroid) TSH 
levels have been described in 2.6-5.5% and above normal (hy-
pothyroid) TSH in 3.3-12.0%.
6-8 Also 7% of the present sample 
were on levothyroxine, which were similar to reports from oth-
er studies with older samples of 4-11%.
7,15
There was a significant association between below normal 
(hyperthyroid) serum TSH levels and cognitive impairment. 
Furthermore, a significant linear association between lower 
TSH levels and cognitive impairment was observed. These re-
sults are consistent with the previous studies reporting associ-
ations between low TSH levels and cognitive impairment
5 or 
incident dementia.
6 Several plausible mechanisms for the as-
sociations have been suggested. Thyroid hormones induce de-
position of β-amyloid changes,
23 and higher thyroid hormone 
levels have been found to be associated with a higher count of 
neocortical neuritic plaque
24 and smaller hippocampal vol-
ume.
25 However, some large epidemiological studies of older 
populations have failed to find this association.
7,8 Discrepant 
findings might be due to the fact that the proportions of par-
ticipants with below or above normal TSH levels are relatively 
small in each study, and so results may vary related to low sta-
tistical power. In addition, TSH values may be altered by as 
much as 30% depending on time of day of phlebotomy, and 
the fasting or non-fasting status of participants.
26 Previous stud-
ies finding no associations have tended to be those which have 
analyzed random TSH measures.
7,8 Consistency of blood sam-
pling times is challenging for epidemiological research, but 
blood samples in this study were collected in a fasting state and 
phlebotomy was carried out in the mornings where possible.
There have been some studies finding associations between 
thyroid dysfunction and affective disorders including depres-
sion,
27 while others have found no associations.
7,8,14,15 Inconsis-
tent results might be due to differences in study setting (clini-
cal or community), depression identification (diagnostic instru-
ment or assessment scale), consideration of confounding factors, 
and different TSH assays. Previous studies reporting significant 
associations have tended to use clinical samples
12,28 and may 
not be generalisable to source communities. Epidemiological 
research on the other hand has tended to use brief screening in-
struments rather than diagnostic interviews. In the present study, 
the sample was drawn from community dwelling elders, and de-
pression was also diagnosed using a fully structured instrument 
which itself has been widely used in international epidemiolog-
ical research.
29
We incidentally found a significant association between hy-
perthyroid state and current smoking in the present study. Our 
study was cross-sectional in design, and therefore could not re-
veal the causal relationship between thyroid problem and smok-
ing status.
30 However, this finding was consistent with the previ-
ous well known study reporting that smoking was a risk factor 
for hyperthyroidism.
31
Strengths of the study were that cases of cognitive impair-
ment and depression were identified by well recognized and for-
Table 2. Multi-variate associations with cognitive impairment. Data are odds ratios (95% confidence intervals)
Unadjusted
Adjusted
Model 1 Model 2 Model 3 Model 4
Hyperthyroid state 4.57 (1.24-16.8) 5.42 (1.20-24.4) 6.30 (1.20-33.0) 7.05 (1.36-36.6) 7.12 (1.35-37.5)
Euthyroid state Tertile 1 1.49 (0.69-3.25) 1.73 (0.75-3.98) 1.89 (0.80-4.50) 1.99 (0.82-4.84) 1.97 (0.81-4.81)
Tertile 2 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Tertile 3 0.65 (0.26-1.65) 0.67 (0.25-1.76) 0.69 (0.25-1.90) 0.64 (0.23-1.79) 0.63 (0.22-1.76)
Hypothyroid state 0.65 (0.14-3.05) 0.51 (0.10-2.55) 0.49 (0.09-2.57) 0.42 (0.08-2.30) 0.45 (0.08-2.49)
Model 1 includes age, gender and education, Model 2 includes Model 1+smoking and physical activity, Model 3 includes Model 2+systolic 
blood pressure, diabetes mellitus, total cholesterol and albumin, Model 4 includes Model 3+levothyroxine treatment and depression
35
30
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Figure 1. Unadjusted associations between thyroid function, cogni-
tive impairment and depression. CSID: Community Screening Inter-
view for Dementia, GMS: Geriatric Mental state Schedule.
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mally validated instruments, that the study sample was drawn 
from a community population, and that important factors po-
tentially affecting serum TSH levels were considered in the 
analyses as potential confounding factors. An important lim-
itation of the study was that measures of thyroid function 
other than TSH were not available in the study. In particular in 
the relationships with depression and dementia, it is important 
to distinguish subclinical and clinical thyroid dysfunction, also 
to see whether the effects are dose-dependent, while it was im-
possible in this study due to its limited design. The participa-
tion rate of the study was also low. The main reason for non-
participation was that contact could not be established and the 
reason for this is most likely to be incorrect registrations on the 
national database-in particular, elders registering in urban ar-
eas where their siblings reside, but actually living themselves 
in rural areas. In previous surveys in this region which have in-
cluded both urban and rural samples, participation rates in ur-
ban residents have been found to be substantially lower than 
those in rural areas.
32
Thyroid dysfunction, cognitive impairment, and depression 
are common problems in old individuals. The possible associ-
ations of thyroid dysfunction with cognitive impairment and 
depression are very important, because management of thy-
roid dysfunction is likely to have beneficial effects on both so-
matic and mental health. Furthermore, treatment of thyroid 
dysfunction is relatively straightforward. However, further stud-
ies are still needed to investigate the association more mechanis-
tically. 
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